Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptides.
暂无分享,去创建一个
Anthal I P M Smits | Jolanda Kluin | J. Kluin | C. Bouten | M. Verhaar | P. Dankers | T. Mes | A. Bosman | A. Smits | Patricia Y W Dankers | Carlijn V C Bouten | Marianne C Verhaar | Anton W Bosman | D. Muylaert | J. V. van Dongen | J. Fledderus | E. Sijbesma | Joost O Fledderus | Hanna Talacua | S. Thakkar | Hanna Talacua | Geert C. van Almen | Simone I S Hendrikse | Dimitri E P Muylaert | Geert C van Almen | Joost L J van Dongen | Eline Sijbesma | Tristan Mes | Shraddha H Thakkar | S. I. Hendrikse | Simone I. S. Hendrikse
[1] H. Anders,et al. Tissue Microenvironments Define and Get Reinforced by Macrophage Phenotypes in Homeostasis or during Inflammation, Repair and Fibrosis , 2012, Journal of Innate Immunity.
[2] 杉山 立樹. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches , 2007 .
[3] T. Springer,et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.
[4] Richard T. Lee,et al. Protease-Resistant Stromal Cell–Derived Factor-1 for the Treatment of Experimental Peripheral Artery Disease , 2011, Circulation.
[5] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[6] Hirotsugu Kurobe,et al. Concise Review: Tissue‐Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future , 2012, Stem cells translational medicine.
[7] C. Bouten,et al. Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds , 2014, Heart.
[8] F. Baaijens,et al. Thermoplastic elastomers based on strong and well-defined hydrogen-bonding interactions , 2008 .
[9] Jian Yu,et al. The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration. , 2012, Biomaterials.
[10] F. Prósper,et al. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. , 2001, Experimental hematology.
[11] Song Li,et al. Regulation of the Matrix Microenvironment for Stem Cell Engineering and Regenerative Medicine , 2011, Annals of Biomedical Engineering.
[12] Robert David,et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. , 2009, Cell stem cell.
[13] S. Waldman,et al. From In Vitro to In Situ Tissue Engineering , 2014, Annals of Biomedical Engineering.
[14] J. Simon,et al. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. , 2011, Biomaterials.
[15] E. W. Meijer,et al. Reversible polymers formed from self-complementary monomers using quadruple hydrogen bonding. , 1997, Science.
[16] Qiang Zhao,et al. The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration. , 2014, Biomaterials.
[17] Yan Zhao,et al. Absence of CD4 or CD8 lymphocytes changes infiltration of inflammatory cells and profiles of cytokine expression in skin wounds, but does not impair healing , 2014, Experimental dermatology.
[18] Katja Schenke-Layland,et al. Preserved bioactivity and tunable release of a SDF1-GPVI bi-specific protein using photo-crosslinked PEGda hydrogels. , 2014, Biomaterials.
[19] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[20] P. Huijgens,et al. Proteoglycans guide SDF‐1‐induced migration of hematopoietic progenitor cells , 2002, Journal of leukocyte biology.
[21] E. W. Meijer,et al. A modular and supramolecular approach to bioactive scaffolds for tissue engineering , 2005, Nature materials.
[22] S. Sánchez-Ramón,et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. , 2011, Blood.
[23] Frank P T Baaijens,et al. A mesofluidics-based test platform for systematic development of scaffolds for in situ cardiovascular tissue engineering. , 2012, Tissue engineering. Part C, Methods.
[24] K. Komvopoulos,et al. Electrospun bilayer fibrous scaffolds for enhanced cell infiltration and vascularization in vivo. , 2015, Acta biomaterialia.
[25] A. Seifalian,et al. Luminal surface engineering, 'micro and nanopatterning': potential for self endothelialising vascular grafts? , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[26] U. Landmesser,et al. DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages. , 2015, International journal of cardiology.
[27] Kerry A. Daly,et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. , 2012, Acta biomaterialia.
[28] Richard T. Lee,et al. Local Delivery of Protease-Resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction , 2007, Circulation.
[29] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[30] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[31] Bart Meuris,et al. Coating with fibronectin and stromal cell-derived factor-1α of decellularized homografts used for right ventricular outflow tract reconstruction eliminates immune response-related degeneration. , 2014, The Journal of thoracic and cardiovascular surgery.
[32] Frank P T Baaijens,et al. Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering. , 2009, Tissue engineering. Part A.
[33] B. Schlosshauer,et al. The Bispecific SDF1-GPVI Fusion Protein Preserves Myocardial Function After Transient Ischemia in Mice , 2012, Circulation.
[34] R. Claus,et al. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells. , 2010, Cancer research.